Share
Other content recommended for you
- Ethical issues raised by intergenerational monitoring in clinical trials of germline gene modification
- A brief and personal history of ‘what’s in a name’ in reproductive genetics
- Should mitochondrial replacement therapy be funded by the National Health Service?
- Moral reasons to edit the human genome: picking up from the Nuffield report
- Gender “tailored” conceptions: should the option of embryo gender selection be available to infertile couples undergoing assisted reproductive technology?
- Future of global regulation of human genome editing: a South African perspective on the WHO Draft Governance Framework on Human Genome Editing
- Fear and infertility research
- Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
- Preimplantation genetic diagnosis: a step by step guide to recent Italian ethical and legislative troubles
- Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies